Twitxy Saved

64x Bio

Verified account This account is verified. Learn more

@64xbio

Enabling next generation medicines.
Brisbane, CA 64xbio.com Joined July 2018
207 Following 1.4K Followers 164 Posts

Latest posts 5

Pinned post

64x Bio Verified account @64xbio
New product launch: Today we’re launching LV Apex Suite, a new product suite for lentiviral vector production.

This marks 64x Bio’s expansion from AAV into LV — and another step in translating our CellMap-driven VectorSelect platform across new modalities.

LV Apex Suite begins with a high yield engineered HEK293T suspension cell line for transient LV production, with stable systems and additional production-enabling technologies in development.

More broadly, this launch reflects where 64x Bio is headed: expanding CellMap as a data foundation for production biology, and learning from those data computationally to iteratively guide development of better cell lines, reagents, and production systems for viral vectors — and soon, biologics.

To learn more about LV Apex Suite, read our press release below and visit 64xbio.com/lvapexsuite.

Press release: 64xbio.com/articles/64x-b…
64xbio.com LV Apex Suite 64x is an interdisciplinary team of scientists, engineers, and entrepreneurs on a mission to help next generation biologics reach the world. We’re combining our expertise in computational biology,...
3 replies 4 reposts 25 likes 24K views View on X
64x Bio Verified account @64xbio
Thanks @PharmaMfg for covering our LV Apex Suite launch!

To read more about our new product launch, read our press release here: 64xbio.com/articles/64x-b…
#64xBio adds #cellengineering platform to #lentiviralvector manufacturing. The new product suite extends the company's vector production platform beyond #AdenoAssociatedVirus applications to support #lentiviral therapies. pharmamanufacturing.com/industry-news/… #AAVs #viralvectors #biologics
View quoted post on X
64x Bio Verified account @64xbio
We'll be in San Diego next week for #BIO2026! The 64x team will be on the ground and @lexrovner is on two panels on advanced medicines, across AI and manufacturing. If you'll be there, we'd love to meet — reach out to us in the BIO partnering portal or at bd@64xbio.com
64x Bio Verified account @64xbio
Today we’re announcing AAV Apex Suite, a powerful suite of tools for end-to-end AAV production.

The future of medicine is taking shape, but scaling it remains a challenge. Some of the biggest breakthroughs in gene therapy continue to be held back by manufacturing constraints. Overcoming this barrier will be a key step in moving the field forward.

AAV Apex Suite includes engineered suspension-adapted HEK293 clonal cell lines and robust, transfer-ready processes built around commercially available consumables. Our cell lines have been independently confirmed by partners across multiple scales, serotypes, and therapeutic payloads at high titer and quality.

As an initial demonstration of our VectorSelect platform, AAV Apex cell lines already achieve unconcentrated bioreactor titers over E15 viral genomes per liter.

Read our press release: 64xbio.com/articles/64x-b…

Learn more about AAV Apex Suite, our VectorSelect platform, and how to work with us, on our new website at 64xbio.com, developed in collaboration with the talented team at Bunsen!